We are monitoring the impact of COVID-19 on North America Diabetes Devices Market Get in touch with us for detailed analysis Know More
Pulished Date April, 2021
ID: 81
Share on
Share on

North America Diabetes Devices Market Analysis - By Device Type & By Country (United States, Canada, Mexico and Rest of North America) - Industry Analysis, Size, Share, Growth, Trends, Forecast (2021 to 2026)

Pulished: April, 2021
ID: 81
Pages: 145

North America Diabetes Devices Market Size (2021 to 2026)

The Diabetes Devices Market in North America has been estimated at USD 8.55 billion in 2021. It is projected to reach USD 10.96 billion by 2026, at a CAGR of 5.08% during the forecast period from 2021 to 2026. Diabetes is a group of metabolic disorders, a chronic condition associated with an abnormally high level of sugar (glucose) in the blood. North America currently witnesses 44.3 million people affected with Diabetes, which will reach 60.5 million by 2040. 

In the years to come, the WHO has predicted Diabetes as one of the leading causes of death. The increased number of patients with Diabetes has resulted in an increased demand for tools for diabetes care. Often contributing to the development of the global market for diabetes care devices resulted in faster and more effective diagnostic methods. Owing to poor eating habits and lack of physical activity, the geriatric population is particularly susceptible to Diabetes. It has led to increased demand for diabetes care products, driving the growth of the industry.

Besides, increased awareness of diabetes care and similar government actions has driven the growth of the global market for diabetes care devices. Wide-ranging advances in healthcare infrastructure and economic progress have had a favorable impact on the market.

Notwithstanding these market-friendly factors, some restrictions may impede their development. Less awareness of the use of devices in remote and underdeveloped areas in the region may, to some degree, prevent the global market for diabetes care devices. There is also a danger to the industry from the lengthy registration periods and reimbursement problems. One of the other significant factors hindering diabetes care devices' market growth in North America is the low average expenditure on Diabetes per person. Besides, compensation dearth and stringent regulations imposed by the government also restrict the market growth in the region.

Over the past few years, with the exponential increase in the cost related to Diabetes, cost-efficient pen needle development will have a significant impact on the growth of the market for diabetes care devices in North America in the years ahead. Enhancing patent terms for profitable products is an effective method to avoid competition and expand North America's product sales. There are several ways of providing insulin to the body, including needles, insulin pens, and insulin pumps. Besides, the healthcare sector's innovation is pushing competitors for change in insulin delivery systems research and development and provides lucrative growth opportunities to the North America Diabetes Devices market.

This research report on the North America Diabetes Devices Market has been segmented and sub-segmented into the following categories:

By Type: 

  • Glucose Monitoring Devices
    • Self-Blood Glucose Monitoring Devices
      • Glucose Meters
      • Test strips
      • Lancets
      • Hemoglobin A1C Testing Kits    
    • Continuous Glucose Monitoring Devices
  • Insulin Delivery Systems
    • Insulin Syringes
    • Insulin Pens
    • Insulin Pumps
    • Jet Injectors
  • Control Solutions

By Country: 

  • The United States
  • Canada
  • Rest of North America

Geographically, North America is segmented into the USA and Canadian markets. North America tops the Global Diabetes Devices Market, with the USA contributing the maximum to the North American market share. Many top companies are based in North America, so it provides the majority of the market share. The National Diabetes Prevention Program by the U.S Department of Health & Human Services is a public-private partnership of community organizations, private insurers, employers, government agencies, and health care organizations. They work to establish local evidence-based lifestyle change programs for people at higher risk for type 2 diabetes. In this way, private companies partnering with the public sector will create an enormous scope in expanding the market in North America.

The most promising companies in the North America Diabetes Devices Market profiled in this report are Roche Diagnostics, Johnson & Johnson, Abbott Laboratories, Novo Nordisk, Ascensia, Tandem Terumo.

  1. Introduction

                1.1 Market Definition                                                    

                1.2 Study Deliverables                                                  

                1.3 Base Currency, Base Year and Forecast Periods                                                          

                1.4 General Study Assumptions                                                

  1. Research Methodology

                2.1 Introduction                                                               

                2.2 Research Phases                                                      

                                2.2.1 Secondary Research                                           

                                2.2.2 Primary Research                                 

                                2.2.3 Econometric Modelling                                      

                                2.2.4 Expert Validation                                  

                2.3 Analysis Design                                                         

                2.4 Study Timeline                                                          

  1. Overview

                3.1 Executive Summary                                                

                3.2 Key Inferences                                                         

                3.3 New Developments                                               

  1. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)

                4.1 Market Drivers                                                          

                4.2 Market Restraints                                                    

                4.3 Key Challenges                                                         

                4.4 Current Opportunities in the Market                                                              

  1. Market Segmentation

                5.1 Global Diabetes Care Devices Market, by Type                                                           

                                5.1.1 Glucose Monitoring Devices                                            

                                       Self Blood Glucose Monitoring Devices                   

                                                       Glucose Meters             

                                                       Test strips        


                                                       Hemoglobin A1C testing Kits    

                                       Continous Glucose Monitoring Devices                  

                                5.1.2 Insulin Delivery Systems                                   

                                       Insulin Syringes                 

                                       Insulin Pens                        

                                       Insulin Pumps                    

                                       Jet Injectors                        

                                5.1.3 Control Solutions                                  

  1. Geographical Analysis

                                6.1 Introduction                                               

                                6.2 United States                                            

                                6.3 Canada                                         

  1. Strategic Analysis

                7.1 PESTLE analysis                                                         

                                7.1.1 Political                                     

                                7.1.2 Economic                                 

                                7.1.3 Social                                         

                                7.1.4 Technological                                         

                                7.1.5 Legal                                          

                                7.1.6 Environmental                                       

                7.2 Porter’s Five analysis                                                              

                                7.2.1 Bargaining Power of Suppliers                                        

                                7.2.2 Bargaining Power of Consumers                                    

                                7.2.3 Threat of New Entrants                                     

                                7.2.4 Threat of Substitute Products and Services                                              

                                7.2.5 Competitive Rivalry within the Industry                                     

  1. Market Leaders' Analysis

                8.1 F. Hoffmann-La Roche Ltd                                                    

                                8.1.1 Overview                                 

                                8.1.2 Product Analysis                                   

                                8.1.3 Strategic Evaluation and Operations                                            

                                8.1.4 Financial analysis                                  

                                8.1.5 Legal issues                                             

                                8.1.6 Recent Developments                                       

                                8.1.7 SWOT analysis                                       

                                8.1.8 Analyst View                                          

                8.2 Medtronic Inc.                                                          

                8.3 Johnson & Johnson                                                 

                8.4 Abbott Laboratories                                                               

                8.5 Becton, Dickinson and Company                                                       

                8.6 Ascensia Diabetes care                                                          

                8.7 Novo Nordisk A/S                                                    

                8.8 Dexcom, Inc.                                                              

                8.9 Insulet Corporation                                                 

                8.10 Terumo Corporation                                                            

                8.11 Tandem Diabetes Care, Inc                                               

                8.12 Ypsomed AG                                                           

  1. Competitive Landscape

                9.1 Market share analysis                                                            

                9.2 Merger and Acquisition Analysis                                                       

                9.3 Agreements, collaborations and Joint Ventures                                                         

                9.4 New Product Launches                                                         

  1. Expert Opinions

                10.1 Market Outlook                                                     

                10.2 Investment Opportunities                                                 


  1. List of Tables
  2. List of Figures
  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. North America Diabetes Devices Market by Region from 2021 to 2026 (USD Million)
  2. North America Diabetes Devices Market by Type from 2021 to 2026 (USD Million)
  3. North America Glucose Monitoring Devices Market by Type from 2021 to 2026 (USD Million)
  4. North America Self Monitoring Blood Glucose (SMBG) Market by Type from 2021 to 2026 (USD Million)
  5. North America Insulin Delivery Devices Market by Type from 2021 to 2026 (USD Million)
  6. USA Diabetes Devices Market by Type from 2021 to 2026 (USD Million)
  7. USA Glucose Monitoring Devices Market by Type from 2021 to 2026 (USD Million)
  8. USA Self Monitoring Blood Glucose (SMBG) Market by Type from 2021 to 2026 (USD Million)
  9. USA Insulin Delivery Devices Market by Type from 2021 to 2026 (USD Million)
  10. Canada Diabetes Devices Market by Type from 2021 to 2026 (USD Million)
  11. Canada Glucose Monitoring Devices Market by Type from 2021 to 2026 (USD Million)
  12. Canada Self Monitoring Blood Glucose (SMBG) Market by Type from 2021 to 2026 (USD Million)
  13. Canada Insulin Delivery Devices Market by Type from 2021 to 2026 (USD Million)

Please wait. . . . Your request is being processed

Related Reports


$ 1234 3335

Click for Request Sample